{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=17700&ordering=name","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=17660&ordering=name","results":[{"accession":"CLO:0021360","name":"GM11629 cell","definition":"[' NEUROMATA, MUCOSAL, WITH ENDOCRINE TUMORS']","term_type":"cell line"},{"accession":"CLO:0021354","name":"GM11630 cell","definition":"[' MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1']","term_type":"cell line"},{"accession":"CLO:0021357","name":"GM11631 cell","definition":"[' MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1']","term_type":"cell line"},{"accession":"CLO:0021365","name":"GM11632 cell","definition":"[' ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE']","term_type":"cell line"},{"accession":"CLO:0021368","name":"GM11633 cell","definition":"[' ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE']","term_type":"cell line"},{"accession":"CLO:0021362","name":"GM11634 cell","definition":"[' ARGININEMIA']","term_type":"cell line"},{"accession":"CLO:0021319","name":"GM11635 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0021321","name":"GM11636 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0021323","name":"GM11637 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0021324","name":"GM11638 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0021326","name":"GM11639 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0021329","name":"GM11654 cell","definition":"[' EWING SARCOMA BREAKPOINT REGION 1; EWSR1, INCLUDED; EWS, INCLUDED; ES, INCLUDED TRANSLOCATED CHROMOSOME']","term_type":"cell line"},{"accession":"CLO:0021330","name":"GM11661 cell","definition":"[' GLYCOGEN STORAGE DISEASE II GLUCOSIDASE, ALPHA, ACID; GAA']","term_type":"cell line"},{"accession":"CLO:0021332","name":"GM11672 cell","definition":"[' CHROMOSOME DELETION']","term_type":"cell line"},{"accession":"CLO:0021335","name":"GM11675 cell","definition":"[' INVERTED CHROMOSOME']","term_type":"cell line"},{"accession":"CLO:0021336","name":"GM11677 cell","definition":"[' OSTEOGENESIS IMPERFECTA: AUTOSOMAL DOMINANT- 166200,166210,166220, OR 166230']","term_type":"cell line"},{"accession":"CLO:0021285","name":"GM11678 cell","definition":"[' TRANSLOCATED CHROMOSOME']","term_type":"cell line"},{"accession":"CLO:0021302","name":"GM11679 cell","definition":"[' ADDITIONAL HUMAN/MOUSE SOMATIC CELL HYBRIDS']","term_type":"cell line"},{"accession":"CLO:0021304","name":"GM11685 cell","definition":"[' ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 17 SOMATIC CELL HYBRIDS CHROMOSOME 22 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS']","term_type":"cell line"},{"accession":"CLO:0021298","name":"GM11686 cell","definition":"[' ADDITIONAL HUMAN/MOUSE SOMATIC CELL HYBRIDS']","term_type":"cell line"}]}